Pharmaceutical - Pharmaceutical, Markets & Marketing

Filter

Popular Filters

1 to 25 of 1116 results

Belsomra could become first-line insomnia therapy, says GlobalData

Belsomra could become first-line insomnia therapy, says GlobalData

18-08-2014

Insomnia treatment Belsomra (suvorexant) from US pharma giant Merck & Co has the potential to become…

BelsomraChemistryCyclopyrrolonesInsomniaMarkets & MarketingMerck & CoNeurologicalOrganic chemistryPharmaceuticalUSA

Turkish man pleads guilty to importing illegal cancer drugs into USA

Turkish man pleads guilty to importing illegal cancer drugs into USA

17-08-2014

Sabahaddin Akman, owner of the Istanbul, Turkey, firm Ozay Pharmaceuticals, has pleaded guilty to charges…

AvastinLegalMarkets & MarketingOncologyOzay PharmaceuticalsPharmaceuticalRituxanSabahaddin AkmanTurkeyUSA

New treatments will partially compensate for unipolar depression drugs coming out of patent

New treatments will partially compensate for unipolar depression drugs coming out of patent

14-08-2014

New antidepressants and antipsychotics will offset a steep decline in sales following genericization…

Antidepressant therapiesDecision Resources GroupGlobalMarkets & MarketingNeurologicalPharmaceuticalPsychiatryUnipolar depression

Global asthma market to hit $18 billion by 2021 boosted by biologics

Global asthma market to hit $18 billion by 2021 boosted by biologics

14-08-2014

The market for asthma drugs is predicted to reach $18 billion by 2021, according to new research from…

AdvairAsthmaAstraZenecaBoehringer IngelheimBreoGlaxoSmithKlineGlobalMarkets & MarketingNatasha SpillerPharmaceuticalRespiratory and PulmonaryRespiratory therapySpirivaSymbicort

Asia Healthcare Forum identifies challenges ahead for meetings in the sector

Asia Healthcare Forum identifies challenges ahead for meetings in the sector

13-08-2014

The inaugural Healthcare Meetings Forum Asia was over-subscribed on August 1 at Suntec Singapore, an…

Asia-PacificMarkets & MarketingPharmaceuticalRegulationSingapore

Strong growth forecast for Saudi Arabia pharmaceuticals market

Strong growth forecast for Saudi Arabia pharmaceuticals market

13-08-2014

Pharmaceuticals products sales in Saudi Arabia are expected to exceed a value of $ 7 billion by 2018,…

Business FinanceFinancialMarkets & MarketingPharmaceuticalProductionRest of the WorldSaudi Arabia

Ukraine may face drugs shortage this year

Ukraine may face drugs shortage this year

11-08-2014

Ukraine plans to ban pharmaceutical imports from Russia, except 20 vital drugs, the analogues of which…

Markets & MarketingPharmaceuticalPoliticsPricingRussiaUkraine

Imatinib and sunitinib will continue to dominate patient share in GIST treatment

Imatinib and sunitinib will continue to dominate patient share in GIST treatment

11-08-2014

The treatment landscape of gastrointestinal stromal tumors (GIST) will not change dramatically through…

BayerGleevecGlivecMarkets & MarketingNovartisOncologyPfizerPharmaceuticalStivargaSutent

Russia may restrict drug imports from Western countries

Russia may restrict drug imports from Western countries

11-08-2014

The Russian Federation Council, the upper house of the Federal Assembly of the country, has put forward…

Drug safetyHealthcareMarkets & MarketingPharmaceuticalPoliticsRussia

Brazil's pharma market has potential for 10% annual growth

Brazil's pharma market has potential for 10% annual growth

11-08-2014

Brazil’s pharma market has the potential to grow by more than 10% per year, according to the head of…

BrazilMarkets & MarketingPharmaceuticalPharmaceutical industry

Belgian pharma trade body issues recommendations on domestic drug shortages

Belgian pharma trade body issues recommendations on domestic drug shortages

11-08-2014

Belgium’s pharmaceutical trade body, pharma.be, has issued a conclusion of its report on the shortage…

BelgiumMarkets & MarketingPharmaceuticalRegulation

MS market to reach $20 billion in 2023 boosted by five new therapies

MS market to reach $20 billion in 2023 boosted by five new therapies

08-08-2014

The forecast launch of five immunomodulatory therapies for relapsing forms of multiple sclerosis will…

CNS DiseasesEuropeImmunosuppressantsJapanMarkets & MarketingMSPharmaceuticalUSA

Nicox and Bausch + Lomb to co-promote latanoprostene bunod for glaucoma

Nicox and Bausch + Lomb to co-promote latanoprostene bunod for glaucoma

08-08-2014

International opthalmic company Nicox is to co-promote latanoprostene bunod with Bausch + Lomb, the eyecare…

Bausch & LombCanadaGlaucomaLatanoprost OphthalmicMarkets & MarketingNicOxOphthalmicsOpticsPharmaceuticalUSA

Mexico’s health care market to reach almost $28 billion by 2020

Mexico’s health care market to reach almost $28 billion by 2020

07-08-2014

Mexico’s pharmaceutical and medical devices industries will be worth around $22.5 billion and $5.4…

Business FinanceMarkets & MarketingMexicoNon-communicable diseasesPharmaceuticalPharmaceutical and medical devices industriesPharmacologyPharmacy

Access and Norgine to partner on MuGard in European territories

Access and Norgine to partner on MuGard in European territories

07-08-2014

Emerging biopharma company Access Pharmaceuticals has entered into an exclusive license agreement with…

Access PharmaceuticalsAccess Pharmaceuticals, Inc.AnalgesiaEuropeMarkets & MarketingMucositisMuGardNorginePharmaceutical

Lilly and Boehringer closing in on diabetes market lead with Jardiance approval

Lilly and Boehringer closing in on diabetes market lead with Jardiance approval

07-08-2014

With the recent approval of Jardiance (empagliflozin) in the USA, Eli Lilly and its partner, German family-owned…

Boehringer IngelheimDiabetesEli LillyEli Lilly and CompanyJanuviaJardianceMarkets & MarketingMerck & CoPharmaceuticalTradjenta

Sanofi partners with Emcure for oncology portfolio in India

Sanofi partners with Emcure for oncology portfolio in India

06-08-2014

French pharma major Sanofi’s Indian subsidiary said today that it has entered into a marketing and…

Emcure PharmaceuticalsFasturtecFludaraIndiaJevtanaMarkets & MarketingOncologyPharmaceuticalSanofiTaxotere

Walgreens to buy remainder of Boots Alliance, but shuns inversion

06-08-2014

US pharmacy giant Walgreen has exercised its option to buy the remaining 55% of European pharmacy retailer…

Alliance BootsEuropeMarkets & MarketingMergers & AcquisitionsPharmaceuticalWalgreens

Existing diabetes drug Victoza could be effective treatment for world’s obese

Existing diabetes drug Victoza could be effective treatment for world’s obese

06-08-2014

Pharmaceutical companies are racing to find a new form of obesity drug as patient numbers spiral and…

Anti-diabetic drugsDiabetesGastro-intestinalsGlobalMarkets & MarketingNovo NordiskPeptide hormonesPharmaceuticalVictoza

EXPERT VIEW: How can pharmaceutical companies adapt to the digital era?

EXPERT VIEW: How can pharmaceutical companies adapt to the digital era?

06-08-2014

‘Digital pharma’ is by no means a new concept for pharmaceutical marketers. But what is new is that…

FinancialGlobalMarkets & MarketingPharmaceutical

Aeterna Zentaris and Ascend Therapeutics team up to market each other's products

Aeterna Zentaris and Ascend Therapeutics team up to market each other's products

05-08-2014

Quebec-based biopharma drug developer Aeterna Zentaris has said it is to collaborate with women’s healthcare…

AEterna ZentarisAscend PharmaClinical researchDavid DoddEstroGelHealthcare specialistMarkets & MarketingPharmaceuticalPharmaceutical sciencesUSAWomen's Health

US and European orphan status for AbbVie’s glioblastoma candidate

US and European orphan status for AbbVie’s glioblastoma candidate

04-08-2014

Both the European Medicines Agency and the US Food and Drug Administration have granted orphan drug designation…

AbbVieABT-414Brain tumorEuropeGlioblastoma multiformeMarkets & MarketingOncologyPharmaceuticalRare diseasesRegulationUS Food and Drug AdministrationUSA

Albumin sales to play major part in growth of billion-dollar critical care market

Albumin sales to play major part in growth of billion-dollar critical care market

31-07-2014

The critical care market across eight major countries will grow to $2.5 billion by 2020, according to…

AlbuminBlood proteinsGlobalMarkets & MarketingPharmaceutical

Acute coronary syndrome treatment market to more than triple by 2023

Acute coronary syndrome treatment market to more than triple by 2023

30-07-2014

The launch of several drugs with “extraordinary blockbuster potential” will cause the acute coronary…

Acute coronary syndromealirocumabAmgenBayerCardio-vascularEuropeevolocumabJapanMarkets & MarketingMerck & CoPfizerPharmaceuticalSanofiUSAXareltoZontivity

1 to 25 of 1116 results

Back to top